Cargando…

Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell

Respiratory virus infections initiate in the upper respiratory tract (URT). Innate immunity is critical for initial control of infection at this site, particularly in the absence of mucosal virus-neutralising antibodies. If the innate immune response is inadequate, infection can spread to the lower...

Descripción completa

Detalles Bibliográficos
Autores principales:	Girkin, Jason L.N., Maltby, Steven, Bartlett, Nathan W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488969/ https://www.ncbi.nlm.nih.gov/pubmed/35508333 http://dx.doi.org/10.1183/16000617.0274-2021

Ejemplares similares

Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections
por: Christopher, ME, et al.
Publicado: (2011)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

In vivo experimental models of infection and disease
por: Girkin, Jason, et al.
Publicado: (2019)

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Trial Watch: Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Experimental Toll-like receptor agonists for cancer therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Bibliometric analysis of toll-like receptor agonists associated with cancer therapy
por: Li, Wei, et al.
Publicado: (2022)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

Toll-like Receptors in Viral Encephalitis
por: Gern, Olivia Luise, et al.
Publicado: (2021)

Extracellular RNA in viral–host interactions: Thinking outside the cell
por: Ressel, Sarah, et al.
Publicado: (2019)

Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2012)

Thinking outside the box
por: Peeraer, G.
Publicado: (2013)

Thinking Outside of the Box
por: Kalantar Motamedi, Mohammad Hosein
Publicado: (2012)

Thinking outside the cranium
por: Sadeghi, Anahita, et al.
Publicado: (2014)

THINKING OUTSIDE OF THE LUNGS
por: Hogg, Meadhbh, et al.
Publicado: (2021)

Thinking Outside the Box
por: Trevas, Sara, et al.
Publicado: (2022)

Think outside the pox
por: Frederick, Abbye W., et al.
Publicado: (2023)

Impact of Selected Bacterial and Viral Toll-like Receptor Agonists on the Phenotype and Function of Camel Blood Neutrophils
por: Hussen, Jamal, et al.
Publicado: (2023)

Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia
por: Hatchwell, Luke, et al.
Publicado: (2015)

The Toll-Like Receptor Agonist Imiquimod Is Active against Prions
por: Oumata, Nassima, et al.
Publicado: (2013)

Trial Watch: Toll-like receptor agonists in oncological indications
por: Aranda, Fernando, et al.
Publicado: (2014)

Anti-tumor Activity of Toll-Like Receptor 7 Agonists
por: Chi, Huju, et al.
Publicado: (2017)

The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
por: Huang, Lingling, et al.
Publicado: (2022)

Toll-Like Receptors: Are They Taking a Toll on the Heart in Viral Myocarditis?
por: Favere, Kasper, et al.
Publicado: (2021)

Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
por: Rolfo, Christian, et al.
Publicado: (2023)

Dysphagia: Thinking outside the box
por: Philpott, Hamish, et al.
Publicado: (2017)

Role of toll-like receptors in respiratory diseases
por: Crespo-Lessmann, Astrid, et al.
Publicado: (2010)

Combining vasculature disrupting agent and toll-like receptor 7/8 agonist for cancer therapy
por: Seth, Anushree, et al.
Publicado: (2016)

Synthesis and Immunological Characterization of Toll-Like Receptor 7 Agonistic Conjugates
por: Chan, Michael, et al.
Publicado: (2009)

Toll-like receptor 2 agonists inhibit human fibrocyte differentiation
por: Maharjan, Anu S, et al.
Publicado: (2010)

The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies
por: Martinsen, Janne Tegder, et al.
Publicado: (2020)

Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists
por: Macedo, Amanda B., et al.
Publicado: (2019)

Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
por: Liu, Zhi-Mei, et al.
Publicado: (2022)

Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
por: Chakraborty, Samik, et al.
Publicado: (2023)

The Toll‐like receptor 7 agonist imiquimod increases ethanol self‐administration and induces expression of Toll‐like receptor related genes
por: Lovelock, Dennis F., et al.
Publicado: (2022)

Think outside the box: extrapulmonary manifestations of severe respiratory syncytial virus infection
por: Thorburn, Kentigern, et al.
Publicado: (2006)

Thinking outside the blood: Perspectives on tissue-resident Trypanosoma brucei
por: Crilly, Nathan P., et al.
Publicado: (2021)

To transfuse or not to transfuse: thinking outside the box
por: Sakr, Yasser, et al.
Publicado: (2010)

Glycogenic Hepatopathy: Thinking Outside the Box
por: Parmar, Nishant, et al.
Publicado: (2015)

Vaccine refrigeration: Thinking outside of the box
por: McColloster, Patrick J, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0rjpjhgfkrttfk3nrimoji0j0v